← Browse by Condition
Medical Condition

fallopian tube cancer

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2
NCT06342986 Phase 1
Recruiting

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Enrollment
33 pts
Location
United States
Sponsor
Masonic Cancer Center, Univers...
View Trial →
NCT07024784 Phase 2
Recruiting

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Enrollment
377 pts
Location
United States, Israe...
Sponsor
AbbVie
View Trial →
NCT06735326 Phase 2
Recruiting

Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer

Enrollment
105 pts
Location
China
Sponsor
Qilu Hospital of Shandong Univ...
View Trial →
NCT05200260 Phase 2
Recruiting

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Enrollment
220 pts
Location
China
Sponsor
Shanghai Gynecologic Oncology ...
View Trial →